These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 10748695)

  • 41. Nurses improve medication safety with medication allergy and adverse drug reports.
    Valente S; Murray L; Fisher D
    J Nurs Care Qual; 2007; 22(4):322-7. PubMed ID: 17873729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Adverse events following immunisation associated with the 1998 Australian Measles Control Campaign.
    D'Souza RM; Campbell-Lloyd S; Isaacs D; Gold M; Burgess M; Turnbull F; O'Brien E
    Commun Dis Intell; 2000 Feb; 24(2):27-33. PubMed ID: 10758692
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Adverse drug effects: involvement of physicians demanded].
    Hügler S
    Dtsch Med Wochenschr; 2009 Apr; 134(17):p16. PubMed ID: 19399721
    [No Abstract]   [Full Text] [Related]  

  • 44. National surveillance of emergency department visits for outpatient adverse drug events in children and adolescents.
    Cohen AL; Budnitz DS; Weidenbach KN; Jernigan DB; Schroeder TJ; Shehab N; Pollock DA
    J Pediatr; 2008 Mar; 152(3):416-21. PubMed ID: 18280852
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decision support methods for the detection of adverse events in post-marketing data.
    Hauben M; Bate A
    Drug Discov Today; 2009 Apr; 14(7-8):343-57. PubMed ID: 19187799
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Classification of ADRs: a proposal for harmonization and differentiation based on the experience of the Comprehensive Hospital Drug Monitoring Bern/St. Gallen, 1974-1993.
    Hunziker T; Bruppacher R; Kuenzi UP; Maibach R; Braunschweig S; Halter F; Hoigné RV
    Pharmacoepidemiol Drug Saf; 2002 Mar; 11(2):159-63. PubMed ID: 11998541
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The incidence and reporting of adverse drug reactions in the Division of Psychiatry.
    Brown P; Faloon L
    Pharm World Sci; 2001 Oct; 23(5):181-2. PubMed ID: 11721674
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Vaccine complications].
    Bourquin C; Zimmermann HP; Desgrandchamps D; Kuhn M
    Rev Med Suisse Romande; 1998 Apr; 118(4):363-70. PubMed ID: 9623289
    [No Abstract]   [Full Text] [Related]  

  • 49. [Open letter of Karl. H. Beine (Professional Circle of Physician Directors for Psychiatry and Psychotherapy in German General Hospitals) on the topic of "Institutional Construction in Gütersloh", Psychiat Prax 2005; 32:372-373].
    Psychiatr Prax; 2006 Mar; 33(2):100. PubMed ID: 16514588
    [No Abstract]   [Full Text] [Related]  

  • 50. Cause and effect? Assessing postmarketing safety studies as evidence of causation in products liability cases.
    Shea LL; Hanson A; Guglielmetti TM; Levy K
    Food Drug Law J; 2007; 62(3):445-72. PubMed ID: 17915388
    [No Abstract]   [Full Text] [Related]  

  • 51. Serious adverse drug events reported to the Food and Drug Administration, 1998-2005.
    Moore TJ; Cohen MR; Furberg CD
    Arch Intern Med; 2007 Sep; 167(16):1752-9. PubMed ID: 17846394
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cutaneous adverse drug reactions to psychotropic drugs and their risk factors - a case-control study.
    Greil W; Zhang X; Stassen H; Grohmann R; Bridler R; Hasler G; Toto S; Bleich S; Kasper S
    Eur Neuropsychopharmacol; 2019 Jan; 29(1):111-121. PubMed ID: 30424913
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A systems approach to preventing adverse drug events.
    Anderson JG
    Stud Health Technol Inform; 2003; 92():95-102. PubMed ID: 15455844
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adverse Drug Reaction Project.
    Blustein JN; Miesbauer KM; Saine D; Williams NF; Gold JA
    Wis Med J; 1997 Mar; 96(3):48-9. PubMed ID: 9086860
    [No Abstract]   [Full Text] [Related]  

  • 55. The US drug safety system: role of the pharmaceutical industry.
    Gibson BR; Suh R; Tilson H
    Pharmacoepidemiol Drug Saf; 2008 Feb; 17(2):110-4. PubMed ID: 17724741
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Adverse drug events and medication errors in psychiatry: methodological issues regarding identification and classification.
    Mann K; Rothschild JM; Keohane CA; Chu JA; Bates DW
    World J Biol Psychiatry; 2008; 9(1):24-33. PubMed ID: 17853253
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Documentation and evaluation of adverse drug reactions (ADR)--contribution from a poison information center.
    Mey C; Hentschel H; Hippius M; Balogh A
    Int J Clin Pharmacol Ther; 2002 Mar; 40(3):102-7. PubMed ID: 11911597
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strategy for surveillance of adverse drug events.
    Bright RA
    Food Drug Law J; 2007; 62(3):605-16. PubMed ID: 17915403
    [No Abstract]   [Full Text] [Related]  

  • 59. [Interview -- drug legislation -- reporting unexpected adverse drug reactions].
    Ludwig WD
    Pneumologie; 2009 Sep; 63(9):479-80. PubMed ID: 19764017
    [No Abstract]   [Full Text] [Related]  

  • 60. [Detection and evaluation of adverse drug effects].
    Thürmann PA; Schmitt K
    Med Klin (Munich); 2000 May; 95(1 Spec No):4-8. PubMed ID: 10851841
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.